NAFAMOSTAT is a broad-spectrum serine protease inhibitor, a kallikrein inhibitor that inhibits blood clotting and is a potential complement inhibitor.

NAFAMOSTAT is a broad-spectrum serine protease inhibitor, a kallikrein inhibitor that inhibits blood clotting and is a potential complement inhibitor. Suppliers list
Company Name: Xiamen Huijia Biological Technology Co., Ltd.  
Tel: 0592-6020891
Email:
Company Name: Hangzhou Yuxin Biotechnology Co., Ltd.  
Tel: 0571-85958891 15988839755
Email: haoxinbio@163.com
Company Name: Xiamen Research Biotechnology Co., Ltd.  
Tel: 0592-6020891 18906011628
Email: 1562893815@qq.com
NAFAMOSTAT is a broad-spectrum serine protease inhibitor, a kallikrein inhibitor that inhibits blood clotting and is a potential complement inhibitor. Basic information
Product Name:NAFAMOSTAT is a broad-spectrum serine protease inhibitor, a kallikrein inhibitor that inhibits blood clotting and is a potential complement inhibitor.
Synonyms:
CAS:
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
NAFAMOSTAT is a broad-spectrum serine protease inhibitor, a kallikrein inhibitor that inhibits blood clotting and is a potential complement inhibitor. Structure
NAFAMOSTAT is a broad-spectrum serine protease inhibitor, a kallikrein inhibitor that inhibits blood clotting and is a potential complement inhibitor. Chemical Properties
Safety Information
MSDS Information
NAFAMOSTAT is a broad-spectrum serine protease inhibitor, a kallikrein inhibitor that inhibits blood clotting and is a potential complement inhibitor. Usage And Synthesis
NAFAMOSTAT is a broad-spectrum serine protease inhibitor, a kallikrein inhibitor that inhibits blood clotting and is a potential complement inhibitor. Preparation Products And Raw materials
Tag:NAFAMOSTAT is a broad-spectrum serine protease inhibitor, a kallikrein inhibitor that inhibits blood clotting and is a potential complement inhibitor. Related Product Information